Cargando…

Association between hepatitis B vaccine antibody response and CD4 reconstitution after initiation of combination antiretroviral therapy in HIV-infected persons

BACKGROUND: Hepatitis B virus (HBV) vaccine antibody response has been associated with reduced risk of AIDS or death. However, it is unknown whether HBV vaccine responsiveness is associated with improved immune reconstitution during treatment with combination antiretroviral therapy (cART). We evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allen, Kahtonna, Mesner, Octavio, Ganesan, Anuradha, O’Bryan, Thomas A, Deiss, Robert G, Agan, Brian K, Okulicz, Jason F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422266/ https://www.ncbi.nlm.nih.gov/pubmed/25928043 http://dx.doi.org/10.1186/s12879-015-0937-5

Ejemplares similares

Hepatitis B Vaccine Responsiveness and Clinical Outcomes in HIV Controllers
por: Okulicz, Jason F., et al.
Publicado: (2014)

Delayed-type hypersensitivity (DTH) test anergy does not impact CD4 reconstitution or normalization of DTH responses during antiretroviral therapy
por: Minidis, Natascha M, et al.
Publicado: (2014)

Calculated Globulin Adds Predictive Value to Hepatitis B Vaccine Response in HIV-infected Persons Independently of HIV Viral load and CD4 Cell Count
por: O’Bryan, Thomas, et al.
Publicado: (2017)

1566 Factors Associated with 10 Years of Continuous HIV Viral Load Suppression on HAART
por: Bello, Kathryn, et al.
Publicado: (2014)

1561 The Relationship Between Self-reported Adherence and Efavirenz Blood Levels on the Appearance of HIV Viral Load Blips
por: Farmer, Aaron, et al.
Publicado: (2014)

Factors associated with 10 years of continuous viral load suppression on HAART
por: Bello, Kathryn J., et al.
Publicado: (2016)

Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia
por: O’Bryan, Thomas A., et al.
Publicado: (2015)

High-risk Behavior Among U.S. Military HIV-Infected Active-Duty and Retired Personnel
por: Pannebaker, Danielle, et al.
Publicado: (2017)

Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons
por: Pomerantz, Heather S., et al.
Publicado: (2018)

1592 Impact of HAART on Incidence of Primary HIV-Associated Thrombocytopenia
por: O'bryan, Thomas, et al.
Publicado: (2014)

1752 Incident Genitourinary and Extragenital Gonococcal and Chlamydial infections in a Racially Diverse Well Characterized Cohort of HIV-infected Persons with Free Access to Care and Counseling
por: Lee, Tida, et al.
Publicado: (2014)

Self-Testing Is a Feasible and Acceptable Option for Identifying Extra-genital Gonorrhea (GC) and Chlamydia (CT) infections in HIV-Infected Persons
por: Ganesan, Anuradha, et al.
Publicado: (2017)

Factors associated with HIV viral load “blips” and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case–control study
por: Farmer, Aaron, et al.
Publicado: (2016)

Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study
por: Crowell, Trevor A, et al.
Publicado: (2016)

Gonorrhea (GC) and Chlamydia (CT) Infection in a Large, Well-Characterized Military Cohort: Prevalence, Incidence, Site of Infection, and Patient Characteristics
por: Eickhoff, Christa, et al.
Publicado: (2017)

The Impact of Continuous Virologic Suppression on the Development of Non-AIDS Diagnoses
por: Joya, Christie, et al.
Publicado: (2017)

336. Disparities in Cardiovascular Disease Prevention Among Persons Living with HIV in the United States Military Natural History Study
por: Thomas Larson, Derek, et al.
Publicado: (2019)

The Association between Sexually Transmitted Infections, Length of Service and Other Demographic Factors in the U.S. Military
por: Deiss, Robert, et al.
Publicado: (2016)

335. Antiretroviral Therapy Anchor-based Trends in Body Mass Index following Treatment Initiation among Military Personnel with HIV
por: Kline, David, et al.
Publicado: (2019)

602. Factors Associated With Erectile Dysfunction Diagnosis in HIV-Infected Individuals: A Case–Control Study
por: Jansen, Nathan, et al.
Publicado: (2018)

Risk Factors Associated With Chronic Liver Enzyme Elevation in Persons With HIV Without Hepatitis B or C Coinfection in the Combination Antiretroviral Therapy Era
por: Wood, Shannon, et al.
Publicado: (2021)

Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS
por: Marconi, Vincent C., et al.
Publicado: (2011)

571. In a Well-Characterized Cohort with Universal Access to Care and Medications Racial Disparities in HIV Virologic Outcomes Are No Longer Observed
por: Ganesan, Anuradha, et al.
Publicado: (2018)

2248. Changes in Lipid Profiles for Patients to Tenofovir Alafenamide (TAF)-Containing Regimens: Perspectives from a Military HIV-Positive Cohort
por: Ewers, Evan, et al.
Publicado: (2018)

D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events
por: Freiberg, Matthew S., et al.
Publicado: (2016)

601. Prescription Drug Misuse in an HIV-Infected US Military Cohort
por: Deiss, Robert, et al.
Publicado: (2018)

Hepatitis B Vaccine Antibody Response and the Risk of Clinical AIDS or Death
por: Landrum, Michael L., et al.
Publicado: (2012)

Race/ethnicity and HAART initiation in a military HIV infected cohort
por: Johnson, Erica N, et al.
Publicado: (2014)

CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy
por: Aldrete, Sol, et al.
Publicado: (2020)

Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study
por: Marconi, Vincent C, et al.
Publicado: (2010)

Health-related quality of life among military HIV patients on antiretroviral therapy
por: Emuren, Leonard, et al.
Publicado: (2017)

1500. At Risk Drinking Is Common Among HIV-Infected Department of Defense (DoD) Beneficiaries But Was Not Associated with Prevalent GC/CT Infections
por: Ganesan, Anuradha, et al.
Publicado: (2018)

Hepatitis E Virus Infection in HIV-infected Persons
por: Crum-Cianflone, Nancy F., et al.
Publicado: (2012)

369. Association Between Depression and HIV Treatment Outcomes in a US Military Population with HIV Infection
por: Carney, Brandon, et al.
Publicado: (2019)

1263. Anti-Retroviral (ART) Success in an Active Duty Military Cohort from 2002 to 2016, A Model for Ending the HIV Epidemic in the United States
por: Schofield, Christina, et al.
Publicado: (2019)

Antiretroviral Therapy and Viral Suppression Among Active Duty Service Members with Incident HIV Infection — United States, January 2012–June 2018
por: Stahlman, Shauna, et al.
Publicado: (2020)

Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort
por: Lifson, Alan R, et al.
Publicado: (2012)

Immune reconstitution inflammatory syndrome (IRIS) in HIV positive patients initiated on antiretroviral therapy (ART)
por: Achappa, Basavaprabhu, et al.
Publicado: (2012)

Association between depression and HIV treatment outcomes in a US military population with HIV infection
por: Carney, Brandon, et al.
Publicado: (2021)

135 HIV-associated immunodeficiency despite potent antiretroviral therapy with CD4 T cell reconstitution
por: Poonia, Bhawna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9pq9kvg5vasnufar368kpuqj8d